FR2636953B1 - Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques - Google Patents

Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques

Info

Publication number
FR2636953B1
FR2636953B1 FR8812538A FR8812538A FR2636953B1 FR 2636953 B1 FR2636953 B1 FR 2636953B1 FR 8812538 A FR8812538 A FR 8812538A FR 8812538 A FR8812538 A FR 8812538A FR 2636953 B1 FR2636953 B1 FR 2636953B1
Authority
FR
France
Prior art keywords
polypeptides
pharmaceutical
genes encoding
human lymphocytes
biological applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8812538A
Other languages
English (en)
French (fr)
Other versions
FR2636953A1 (fr
Inventor
Thierry Hercend
Frederic Triebel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8812538A priority Critical patent/FR2636953B1/fr
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Priority to AT89402632T priority patent/ATE111920T1/de
Priority to AU44056/89A priority patent/AU638682C/en
Priority to DE68918399T priority patent/DE68918399T2/de
Priority to ES89402632T priority patent/ES2059801T3/es
Priority to PCT/FR1989/000491 priority patent/WO1990003394A2/fr
Priority to JP1510496A priority patent/JP2960453B2/ja
Priority to EP89402632A priority patent/EP0367641B1/fr
Publication of FR2636953A1 publication Critical patent/FR2636953A1/fr
Priority to DK130290A priority patent/DK130290A/da
Application granted granted Critical
Publication of FR2636953B1 publication Critical patent/FR2636953B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8812538A 1988-09-26 1988-09-26 Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques Expired - Fee Related FR2636953B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8812538A FR2636953B1 (fr) 1988-09-26 1988-09-26 Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques
AU44056/89A AU638682C (en) 1988-09-26 1989-09-26 New limphokines, DNA sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
DE68918399T DE68918399T2 (de) 1988-09-26 1989-09-26 Lymphokine, DNS-Sequenzen, die diese Lymphokine kodieren, und sie enthaltende pharmazeutische Zusammensetzungen.
ES89402632T ES2059801T3 (es) 1988-09-26 1989-09-26 Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
AT89402632T ATE111920T1 (de) 1988-09-26 1989-09-26 Lymphokine, dns-sequenzen, die diese lymphokine kodieren, und sie enthaltende pharmazeutische zusammensetzungen.
PCT/FR1989/000491 WO1990003394A2 (fr) 1988-09-26 1989-09-26 Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
JP1510496A JP2960453B2 (ja) 1988-09-26 1989-09-26 新規のリンフォカイン、該リンフォカインをコードするｄｎａ配列及び該リンフォカインを含む医薬組成物
EP89402632A EP0367641B1 (fr) 1988-09-26 1989-09-26 Nouvelles lymphokines, séquences d'ADN codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
DK130290A DK130290A (da) 1988-09-26 1990-05-25 Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8812538A FR2636953B1 (fr) 1988-09-26 1988-09-26 Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques

Publications (2)

Publication Number Publication Date
FR2636953A1 FR2636953A1 (fr) 1990-03-30
FR2636953B1 true FR2636953B1 (fr) 1990-12-14

Family

ID=9370380

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8812538A Expired - Fee Related FR2636953B1 (fr) 1988-09-26 1988-09-26 Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques

Country Status (8)

Country Link
EP (1) EP0367641B1 (da)
JP (1) JP2960453B2 (da)
AT (1) ATE111920T1 (da)
DE (1) DE68918399T2 (da)
DK (1) DK130290A (da)
ES (1) ES2059801T3 (da)
FR (1) FR2636953B1 (da)
WO (1) WO1990003394A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006195A1 (en) * 1990-09-28 1992-04-16 University Of Minnesota Dna and amino acid sequence specific for natural killer cells and t cells
AU5923398A (en) 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
BR122024001145A2 (pt) 2014-03-14 2024-02-27 Novartis Ag Molécula de anticorpo isolada capaz de se ligar a lag-3, seu método de produção, composição farmacêutica, ácidos nucleicos, vetor de expressão, método para detecção de lag-3 em uma amostra biológica, e uso das referidas molécula de anticorpo e composição

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260880A3 (en) * 1986-09-11 1990-03-07 Dana-Farber Cancer Institute, Inc. Turning on of cytotoxicity
US4994369A (en) * 1987-12-15 1991-02-19 The Board Of Trustees Of The Leland Stanford Jr. Univ. T-cell activation related gene

Also Published As

Publication number Publication date
JP2960453B2 (ja) 1999-10-06
WO1990003394A3 (fr) 1990-07-12
DE68918399T2 (de) 1995-03-16
DK130290D0 (da) 1990-05-25
AU638682B2 (en) 1993-07-08
FR2636953A1 (fr) 1990-03-30
DE68918399D1 (de) 1994-10-27
EP0367641B1 (fr) 1994-09-21
DK130290A (da) 1990-05-25
WO1990003394A2 (fr) 1990-04-05
EP0367641A3 (en) 1990-08-29
ATE111920T1 (de) 1994-10-15
ES2059801T3 (es) 1994-11-16
JPH03502697A (ja) 1991-06-20
AU4405689A (en) 1990-04-18
EP0367641A2 (fr) 1990-05-09

Similar Documents

Publication Publication Date Title
FR2656800B1 (fr) Nouvelles proteines produits par les lymphocytes humains, sequence d'adn codant pour ces proteines et applications pharmaceutiques et biologiques.
DK0409472T3 (da) Knoglemorfogenetisk protein
DK0591914T3 (da) Retrovirus fra HIV-gruppen og dets anvendelse
DE69518751D1 (de) Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DK0555435T3 (da) DNA-sekvens, der koder bovint alfa-lactalbumin, og fremgangsmåder til anvendelse
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
ES8704207A1 (es) Procedimiento para preparar una molecula de adn
FR2636953B1 (fr) Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
PT85572A (de) Polypeptide des rhinovirusstammes hrv89 sowie die hierfuer codierenden dna-molekuele
MY101874A (en) Vaccine
FR2723378B1 (fr) Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications
IL88378A (en) Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
FR2699179B1 (fr) Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DE69027967D1 (de) Proteine, die die expression von vertebraten-mhc-klasse-ii-genen regulieren, dafür kodierende dna-sequenzen und pharmazeutische zusammensetzungen
NO921219D0 (no) Somatostatin reseptor
TR199902564T2 (xx) K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
FR2645173B1 (fr) Clonage et expression de genes codant pour des peptides et/ou des fragments de peptides du virus mokola, application a la preparation d'un v
FR2676069B1 (fr) Nouvelles molecules de adn recombinants contenant la partie codante d'une chaine vbeta2 du recepteur pour l'antigene des cellules t, procede de preparation, anticorps et medicaments les renfermant.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse